デフォルト表紙
市場調査レポート
商品コード
1303318

細胞溶解/細胞分画市場:製品タイプ(消耗品、装置)、細胞タイプ(哺乳類細胞、微生物細胞)、用途、エンドユーザー別-2023-2030年の世界予測

Cell Lysis/Cell Fractionation Market by Product (Consumables, Instruments), Cell Type (Mammalian Cells, Microbial Cells), Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 184 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
細胞溶解/細胞分画市場:製品タイプ(消耗品、装置)、細胞タイプ(哺乳類細胞、微生物細胞)、用途、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 184 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞溶解/細胞分画の世界市場は、2023年に33億5,384万米ドル、CAGR 8.53%で大幅な成長が予測され、2030年には驚異的な59億5,741万米ドルに達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の細胞溶解/細胞分画市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーが特定のニーズに基づいて情報に基づいた意思決定を行えるようにします。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.細胞溶解/細胞分画の世界市場規模および予測は?

2.予測期間中、世界の細胞溶解/細胞分画市場を形成するCOVID-19の阻害要因と影響は?

3.細胞溶解/細胞分画の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.細胞溶解/細胞分画の世界市場における競争戦略は?

5.細胞溶解/細胞分画の世界市場における技術動向と規制の枠組みは?

6.細胞溶解/細胞分画の世界市場における主要ベンダーの市場シェアは?

7.細胞溶解/細胞分画の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • ヘルスケア、ライフサイエンス、製薬産業の調査開発活動を無数の分野で拡大
      • 調査に対する政府の資金提供を増やす
      • 病気と診断の増加
    • 抑制要因
      • 細胞ベースの装置と研究のコストが高い
    • 機会
      • 個別化医療への注目の高まり、バイオ医薬品およびバイオテクノロジー産業の拡大
      • HIV/AIDSやがんなどの病気の蔓延
    • 課題
      • 訓練を受けた人材の不足
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 細胞溶解/細胞分画市場:製品別

  • 消耗品
    • ビーズ
    • 使い捨て用品
    • 試薬とキット
  • 楽器
    • ホモジナイザー
    • 超音波処理器

第7章 細胞溶解/細胞分画市場細胞の種類別

  • 哺乳類細胞
  • 微生物細胞

第8章 細胞溶解/細胞分画市場:用途別

  • 核酸の精製と分離
  • タンパク質の精製と分離

第9章 細胞溶解/細胞分画市場:エンドユーザー別

  • バイオ医薬品およびバイオテクノロジー企業
  • 調査および研究所

第10章 南北アメリカの細胞溶解/細胞分画市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の細胞溶解/細胞分画市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの細胞溶解/細胞分画市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CELL LYSIS/CELL FRACTIONATION MARKET RESEARCH PROCESS
  • FIGURE 2. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2022 VS 2030 (%)
  • FIGURE 6. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. CELL LYSIS/CELL FRACTIONATION MARKET DYNAMICS
  • FIGURE 10. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CELL LYSIS/CELL FRACTIONATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 6. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BEADS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY DISPOSABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 11. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY HOMOGENIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY SONICATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY MICROBIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY NUCLEIC ACID PURIFICATION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PROTEIN PURIFICATION & ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 124. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 125. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 130. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 131. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 136. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 149. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 150. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 156. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 161. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 162. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 167. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 168. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 173. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 174. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 179. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 180. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 185. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 186. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 191. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 197. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 198. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 203. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 204. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 209. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 210. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 215. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 216. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 221. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 222. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 227. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 228. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 233. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 239. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 240. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 245. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 246. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 251. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 252. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 257. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 258. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 263. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 264. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM CELL LYSIS/CELL FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. CELL LYSIS/CELL FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 274. CELL LYSIS/CELL FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 275. CELL LYSIS/CELL FRACTIONATION MARKET LICENSE & PRICING
目次
Product Code: MRR-FD3F12D53531

The Global Cell Lysis/Cell Fractionation Market is forecasted to grow significantly, with a projected USD 3,353.84 million in 2023 at a CAGR of 8.53% and expected to reach a staggering USD 5,957.41 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cell Lysis/Cell Fractionation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cell Lysis/Cell Fractionation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Beads, Disposables, and Reagents & Kits. The Instruments is further studied across Homogenizers and Sonicators. The Consumables is projected to witness significant market share during forecast period.

Based on Cell Type, market is studied across Mammalian Cells and Microbial Cells. The Mammalian Cells is projected to witness significant market share during forecast period.

Based on Application, market is studied across Nucleic Acid Purification & Isolation and Protein Purification & Isolation. The Nucleic Acid Purification & Isolation is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Biopharmaceutical & Biotechnology Companies and Research Laboratories & Institutes. The Research Laboratories & Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cell Lysis/Cell Fractionation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cell Lysis/Cell Fractionation Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Lysis/Cell Fractionation Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Lysis/Cell Fractionation Market?

4. What is the competitive strategic window for opportunities in the Global Cell Lysis/Cell Fractionation Market?

5. What are the technology trends and regulatory frameworks in the Global Cell Lysis/Cell Fractionation Market?

6. What is the market share of the leading vendors in the Global Cell Lysis/Cell Fractionation Market?

7. What modes and strategic moves are considered suitable for entering the Global Cell Lysis/Cell Fractionation Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cell Lysis/Cell Fractionation Market, by Product, 2022 vs 2030
  • 4.3. Cell Lysis/Cell Fractionation Market, by Cell Type, 2022 vs 2030
  • 4.4. Cell Lysis/Cell Fractionation Market, by Application, 2022 vs 2030
  • 4.5. Cell Lysis/Cell Fractionation Market, by End-User, 2022 vs 2030
  • 4.6. Cell Lysis/Cell Fractionation Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries research and developmental activities in countless fields
      • 5.1.1.2. Increasing government funding for research
      • 5.1.1.3. Increasing cases of diseases and diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cell-based equipments and researches
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing focus on personalized medicine, and the expansion of biopharmaceutical and biotechnology industries
      • 5.1.3.2. Growing prevalence of diseases such as HIV/AIDS and cancer
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of trained personnel
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Cell Lysis/Cell Fractionation Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Beads
    • 6.2.2. Disposables
    • 6.2.3. Reagents & Kits
  • 6.3. Instruments
    • 6.3.1. Homogenizers
    • 6.3.2. Sonicators

7. Cell Lysis/Cell Fractionation Market, by Cell Type

  • 7.1. Introduction
  • 7.2. Mammalian Cells
  • 7.3. Microbial Cells

8. Cell Lysis/Cell Fractionation Market, by Application

  • 8.1. Introduction
  • 8.2. Nucleic Acid Purification & Isolation
  • 8.3. Protein Purification & Isolation

9. Cell Lysis/Cell Fractionation Market, by End-User

  • 9.1. Introduction
  • 9.2. Biopharmaceutical & Biotechnology Companies
  • 9.3. Research Laboratories & Institutes

10. Americas Cell Lysis/Cell Fractionation Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cell Lysis/Cell Fractionation Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing